Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma.
Xue C, Huang Y, Huang PY, Yu QT, Pan JJ, Liu LZ, Song XQ, Lin SJ, Wu JX, Zhang JW, Zhao HY, Xu F, Liu JL, Hu ZH, Zhao LP, Zhao YY, Wu X, Zhang J, Ma YX, Zhang L.
Xue C, et al. Among authors: huang py, huang y.
Ann Oncol. 2013 Apr;24(4):1055-61. doi: 10.1093/annonc/mds581. Epub 2012 Nov 21.
Ann Oncol. 2013.
PMID: 23172635
Free article.
Clinical Trial.